ArticleActa endocrinologica (Bucharest, Romania : 2005)
CLINICAL AND HISTORICAL PREDICTORS OF GLYCEMIC CONTROL IN TYPE 1 DIABETES PATIENTS USING AUTOMATED INSULIN DELIVERY (AID) SYSTEMS: A RETROSPECTIVE ANALYSIS.
Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Achieving optimal glycemic control in type 1 diabetes mellitus (T1DM) remains challenging despite the use of automated insulin delivery (AID) systems. This study evaluated glycemic outcomes and factors associated with poor control among T1DM patients using AID. Patients and Methods: A descriptive cross-sectional study was conducted among 23 patients with T1DM. Data included demographics, age at diagnosis, duration of AID use, hospitalization, and HbA1c levels. Glycemic control was classified as good (<7%) or poor (≥7%) according to ADA guidelines. Results: Participants were predominantly adults (82.6%), with a mean age of 23.9 ± 7.6 years, and mostly female (73.9%). The mean age at diagnosis was 10.3 ± 6.0 years. Poor glycemic control was observed in 78.3% of patients, with a mean HbA1c of 8.0 ± 1.7%. Better control was significantly associated with older age at diagnosis and AID use for 6-12 months (p < 0.05). HbA1c showed no significant correlations with age, age at diagnosis, or AID duration. Logistic regression identified younger age at diagnosis as the only independent predictor of poor glycemic control. Conclusion: Suboptimal glycemic control remains common among T1DM patients using AID systems. Early age at diagnosis is a key risk factor for poor outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.